A Resource for Healthcare and Social Services Professionals
Estimated time to complete: 2 hours 0 minutes
This training will prepare prescribers to handle practical considerations when treating patients with opioid use disorders in office settings.
This training will provide waivered prescribers the skills needed to actually implement office-based addiction treatment into an ambulatory practice setting. Additionally, this talk will provide expert, concrete tips to facilitate the provision of care for patients with substance use disorders utilizing medications in their treatment.
This training is held as a recorded training. Participants must complete a pre-test, post-test, and post-evaluation to receive credit for attending the training. Participants must score a 7/10 on the post-test.
This is not a training to receive your X-Waiver
Prescribers who have recently obtained their X-Waiver (or who are contemplating getting their waiver) and are looking to increase provision of care for patients with substance use disorder in an outpatient setting.
MPH, MSN, NP-C, CARN-AP
MSN, MPH, NP, CARN-AP
MSN, NP-C, CARN
The learner will be able to:
Identify patients appropriate for a trial of buprenorphine treatment.
Recognize the benefits of providing low barrier access to care.
Discuss the utility of toxicology screening.
Describe examples of a harm reduction approach to managing care for persons with opioid use disorder.
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services (BSAS), Opioid Response Network (ORN)
ACCME Accreditation Statement
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
Boston University School of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.